Clinical Trials Logo

Clinical Trial Summary

This study will explore and map the potential shifts in vaginal microbiomes as a consequence of a microbial intervention with product FB101 in healthy, asymptomatic volunteer women screened to have vaginal dysbiosis based on criteria defined by metagenomic sequencing of a vaginal swab sample.


Clinical Trial Description

This study will explore and map the potential shifts in vaginal microbiomes as a consequence of a microbial intervention with product FB101 in healthy, asymptomatic volunteer women screened to have vaginal dysbiosis based on criteria defined by metagenomic sequencing of a vaginal swab sample. A dose of FB101 will be given on 3 different days and subjects will be followed for changes in their vaginal microbiomes until approximately 6 months after the first FD101 dose. The study includes a screening visit where all criteria for participation are checked and a vaginal swab is obtained to check if pre-defined dysbiosis criteria are met based on metagenomic sequencing. If, and when, all criteria are confirmed, a baseline visit, visit 2, is scheduled to be performed around day 8 of the following menstrual cycle of each individual subject. Besides baseline assessments, the subject is randomised to active FB101 or placebo in a ratio of 3(active): 1(placebo) and the first dose is given. At visit 3 and 4 (performed on day 9 and 10 in the same menstrual cycle as Visit 2) the following 2 doses are given. In total, 7 follow-up visits (visit 5-11) are scheduled to occur for a period of up to 6 months after the first dose. All follow-up visits will be scheduled to occur around day 8 in the subject's menstrual cycle with one menstrual cycle in between visits. At follow up visits, close safety monitoring will be performed as well as metagenomic sequencing assessment of the microbiota in a vaginal swab. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05114031
Study type Interventional
Source Freya Biosciences ApS
Contact Aoife Lonergan
Phone 21 430 7442
Email [email protected]
Status Recruiting
Phase N/A
Start date October 20, 2021
Completion date October 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT03701893 - Evaluate the Use of a New Probiotic Strain in Couples With Fertility Problems and Dysbiosis. N/A
Recruiting NCT04721938 - Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment N/A
Completed NCT03843112 - Modulating the Vaginal Microbiome After Implantation Failure Phase 4
Enrolling by invitation NCT03734523 - Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis
Completed NCT04171947 - Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment N/A
Not yet recruiting NCT04658355 - Chlorhexidine Gluconate Versus Povidone-iodine N/A
Recruiting NCT04202302 - Vaginal Profile in IVF/ICSI and Impact on Clincal Outcome